Curis, Inc. to Present at the Leerink Swann and Company Novel Cancer Therapeutics Roundtable Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference at 1:30 p.m. EDT on May 20, 2009, at the Roosevelt Hotel in New York City.

Back to news